1. Cancer statistics, 2022;Siegel;CA Cancer J. Clin.,2022
2. Cancer statistics, 2021;Siegel;CA Cancer J. Clin.,2021
3. Doxorubicin: The Good, the Bad and the Ugly Effect;Carvalho,2009
4. Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin;Shukla;Mol. Cancer,2010
5. Effect of Apatinib Plus Pegylated Liposomal Doxorubicin vs Pegylated Liposomal Doxorubicin Alone on Platinum-Resistant Recurrent Ovarian Cancer: The APPROVE Randomized Clinical Trial;Wang,2022